Company: NCEL
Filing Date: 2025-03-03
Form Type: F-4/A
Source: 0001213900-25-018981
Chunk: 251

Company: NewcelX Ltd.
Filing Date: 2025-03-03
Form: F-4/A
Chunk 251
---
), and the Nasdaq listing application for initial listing of NLS following the Merger and of NLS Common Shares being issued pursuant to the Merger Agreement shall have been approved. Completion and Effectiveness of the Merger The Closing is expected to take place (i) no later than the second business day following the satisfaction or waiver of the conditions described below under the section titled “ Conditions to the Consummation of the Merger” or (ii) on such other date as agreed to by the parties to the Merger Agreement in writing, in each case, subject to the satisfaction or waiver of the closing conditions. However, because the Merger is subject to a number of conditions, neither NLS nor Kadimastem can predict exactly when the closing of the Merger will occur or if it will occur at all. Termination The Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including: •By mutual written consent of NLS and Kadimastem; •by either NLS or Kadimastem if any of the conditions to Closing have not been satisfied or waived by April30, 2025; 124 •by either NLS or Kadimastem if the other party shall have breached, or failed to comply with, any of its covenants or obligations under the Merger Agreement or any representation or warranty made by such party (or, in the case of NLS, Merger Sub) shall have been incorrect in any respect when made or shall have since ceased to be true and correct in any respect such that certain conditions set forth in the Merger Agreement would not be satisfied and such breach shall not have been cured (or is not capable of being cured) as set forth in the Merger Agreement; •by either NLS or Kadimastem of the other party’s uncured breach (subject to certain materiality qualifiers); •by either NLS or Kadimastem if the NLS shareholder meeting is held and the NLS shareholders’ approval is not received; •by either NLS or Kadimastem if the Kadimastem shareholder meeting is held and the Kadimastem shareholders’ approval is not received; or •by NLS in the event NLS accepts a Parent Superior Proposal. If the Merger Agreement is terminated, all further obligations of the parties under the Merger Agreement will terminate and will be of no further force and effect (except that certain obligations related to public announcements, confidentiality, fees and expenses, termination